Bryn Mawr Capital Management LLC Lowers Stake in Agilent Technologies, Inc. (NYSE:A)

Bryn Mawr Capital Management LLC cut its stake in Agilent Technologies, Inc. (NYSE:A) by 80.4% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,649 shares of the medical research company’s stock after selling 27,339 shares during the period. Bryn Mawr Capital Management LLC’s holdings in Agilent Technologies were worth $893,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA grew its position in Agilent Technologies by 3.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock valued at $2,314,784,000 after acquiring an additional 525,214 shares during the last quarter. State Street Corp boosted its stake in shares of Agilent Technologies by 1.2% in the 3rd quarter. State Street Corp now owns 12,819,897 shares of the medical research company’s stock valued at $1,903,498,000 after purchasing an additional 158,175 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Agilent Technologies by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 6,948,679 shares of the medical research company’s stock valued at $1,028,241,000 after purchasing an additional 30,610 shares during the last quarter. Van ECK Associates Corp raised its position in Agilent Technologies by 8.7% in the 4th quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock worth $434,625,000 after purchasing an additional 258,358 shares during the period. Finally, Nordea Investment Management AB raised its position in Agilent Technologies by 2.6% in the 4th quarter. Nordea Investment Management AB now owns 3,198,715 shares of the medical research company’s stock worth $431,603,000 after purchasing an additional 80,819 shares during the period.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Bank of America reduced their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Sanford C. Bernstein reduced their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday, November 26th. Wells Fargo & Company lowered their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $135.00 to $145.00 in a research note on Monday, February 10th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $144.38.

Agilent Technologies Stock Down 0.3 %

Shares of NYSE A opened at $136.74 on Friday. The firm has a fifty day simple moving average of $141.04 and a two-hundred day simple moving average of $139.28. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $39.01 billion, a PE ratio of 30.94, a price-to-earnings-growth ratio of 3.66 and a beta of 1.07.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The company had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the company earned $1.38 earnings per share. Agilent Technologies’s quarterly revenue was up .8% on a year-over-year basis. Equities analysts expect that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is presently 22.40%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.